This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jagotec Ag. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Pol-Henri Guivarc'H: Innovator in Pharmaceutical Formulations
Introduction
Pol-Henri Guivarc'H is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative oral dosage forms. His work focuses on enhancing the efficacy and delivery of medications.
Latest Patents
Guivarc'H holds a patent for a unique formulation of coated tablets. This patent discloses a pharmaceutically acceptable oral dosage form that includes fenofibrate, phospholipid, a buffer salt, and various bulking agents. The formulation is designed to improve the solubility and bioavailability of fenofibrate, utilizing microparticles coated with phospholipid. This innovative approach aims to optimize the therapeutic effects of the medication.
Career Highlights
Pol-Henri Guivarc'H is associated with Jagotec AG, where he continues to advance his research and development efforts. His expertise in pharmaceutical formulations has positioned him as a key player in the industry. His work is characterized by a commitment to improving patient outcomes through innovative drug delivery systems.
Collaborations
Guivarc'H collaborates with esteemed colleagues, including Michael G Vachon and Mishra K Awadesh. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Pol-Henri Guivarc'H exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to shape the future of drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile